Oligonucleotide therapeutics solution guide
Oligonucleotide therapeutics are nucleic acid polymers generally comprised of a few to several dozen bases (including modified bases) linked together. They are produced by chemical synthesis and act directly on organisms without being translated into proteins. Oligonucleotide therapeutics are characterized by the ability to target specific diseases. However, it is a practical problem that oligonucleotide therapeutics are degraded and excreted rapidly after administration by exonucleases and endonucleases that are abundant in blood and cells.
In this latest eBook, experts from Shimadzu (Kyoto, Japan) explore the various types and characteristics of oligonucleotide therapeutics, the development workflow of these therapeutics and walkthrough both solutions and tools for each stage of the development process.
C10G-E097_Oligonucleotide Therapeutics Solution Guide (1)_compressed (1)
If you would like to learn more about the technology available for liquid chromatography at Shimadzu, click here to find out more
In association with:
